This week’s Research Ethics Roundup looks at the latest US Department of Agriculture (USDA) numbers on animals living in research labs, how researchers are working to better engage diverse populations, President Trump’s decision to keep Dr. Francis Collins as director of the National Institutes of Health (NIH), and the International Committee of Medical Journal Editors (ICMJE)’s final policy on data sharing statements for clinical trials. Read more
From sequencing the human genome to discovering the underlying causes of many diseases, genetic research has the ability to profoundly influence the health of individuals and populations. However, despite genomics’ exceptional capacity to contribute to our understanding of disease, the nature of genetic research introduces many ethical considerations that may not arise in other types of biomedical research. Read more
Over the coming months, I’m going to look more closely at a few areas of the revised rule. I won’t be giving tips on implementation, just pointing out some of what I find interesting in a few specific areas. In this post, I’m going to take a deeper dive into the changes around informed consent, an area that, as I mentioned in my preliminary reflections on the rule, I am pretty excited about. Read more
For this month’s question you are a member of a local IRB reviewing an influenza vaccine study. The investigator wants to ask enrolled study participants to help recruit additional study participants. The investigator wants to express her gratitude for this assistance. She has asked the IRB whether tangible expressions of gratitude, e.g., cash, would be acceptable. Read more
At the beginning of the year, PRIM&R welcomed two new members to its Board of Directors, including Owen Garrick, MD, MBA. We recently had the opportunity to speak with Dr. Garrick about his experiences in the field as well as his involvement with PRIM&R. Read more
This week’s Research Ethics Roundup reviews a Congressional hearing on reducing overhead payments for research oversight, highlights doctors’ arguments for saving the Fogarty International Center at the National Institute of Health (NIH), discusses legal challenges faced by the US Department of Agriculture (USDA) over their decision to delay reposting animal welfare records, and outlines a proposal that allow human subjects to negotiate with the pharmaceutical industry on drug pricing issues.
House Science Panel Joins Trump in Questioning Research Overhead Payments
Jeffrey Mervis reports for Science on a recent Congressional hearing in which representatives reviewed the [...] Read more